Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost–Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration

por Brown, Gary C., Brown, Melissa M., Gierhart, Dennis, Olk, R. Joseph
Publicado 2023

Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis

por Olk, R. Joseph, Peralta, Enrique, Gierhart, Dennis L., Brown, Gary C., Brown, Melissa M.
Publicado 2015